| # | Title | Journal | Year | Citations |
|---|
| 1 | New Multiple Sclerosis Phenotypic Classification | European Neurology | 2014 | 3,135 |
| 2 | The Mental Deterioration Battery: Normative Data, Diagnostic Reliability and Qualitative Analyses of Cognitive Impairment | European Neurology | 1996 | 1,099 |
| 3 | Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets | European Neurology | 2015 | 1,056 |
| 4 | Post-Stroke Fatigue: Epidemiology, Clinical Characteristics and Treatment | European Neurology | 2014 | 929 |
| 5 | Multiple Sclerosis: Current Knowledge and Future Outlook | European Neurology | 2014 | 765 |
| 6 | Motor Evaluation in Vascular Hemiplegia | European Neurology | 1980 | 726 |
| 7 | Staging of Alzheimer-Related Cortical Destruction | European Neurology | 1993 | 685 |
| 8 | Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy | European Neurology | 2016 | 576 |
| 9 | Noninvasive Assessment of Cerebral Perfusion and Oxygenation in Acute Ischemic Stroke by Near-Infrared Spectroscopy | European Neurology | 2009 | 569 |
| 10 | Migraine Headache Triggered Specifically by Sunlight: Report of 16 Cases | European Neurology | 2013 | 461 |
| 11 | Seelenlähmung des “Schauens”, optische Ataxie, räumliche Störung der Aufmerksamkeit. pp. 51–66 | European Neurology | 1909 | 454 |
| 12 | Inter-and Intraobserver Reproducibility of Cerebral Atrophy Assessment on MRI Scans with Hemispheric Infarcts | European Neurology | 1996 | 383 |
| 13 | Neurological and Neuropsychological Bases of Empathy | European Neurology | 1998 | 358 |
| 14 | Neuropathology of Autonomic Nervous System in Parkinson's Disease | European Neurology | 1997 | 335 |
| 15 | The Human Periventricular Arterial Blood Supply and the Anatomy of Cerebral Infarctions | European Neurology | 1971 | 311 |
| 16 | A 52-Week Study of the Efficacy of Rivastigmine in Patients with Mild to Moderately Severe Alzheimer’s Disease | European Neurology | 2000 | 301 |
| 17 | Unintended Return of Consciousness in a Patient during Surgery and General Anesthesia | European Neurology | 2017 | 301 |
| 18 | Pick’s Disease | European Neurology | 1974 | 286 |
| 19 | Dopamine Neurotransmission and Treatments for Parkinson's Disease in the Molecular Biology Era | European Neurology | 1997 | 280 |
| 20 | The Perceived Effects of Smoked Cannabis on Patients with Multiple Sclerosis | European Neurology | 1997 | 273 |
| 21 | High Occurrence Rate of Glaucoma among Patients with Alzheimer’s Disease | European Neurology | 2002 | 266 |
| 22 | Noninvasive Tomographic Study of Cerebral Blood Flow and Oxygen Metabolism in vivo | European Neurology | 1981 | 259 |
| 23 | The Clinical Pharmacology, Pharmacokinetics and Metabolism of Sumatriptan | European Neurology | 1991 | 250 |
| 24 | White Matter Changes on CT and MRI: An Overview of Visual Rating Scales | European Neurology | 1998 | 244 |
| 25 | Comparison of Immediate-Release and Controlled Release Carbidopa/Levodopa in Parkinson’s Disease | European Neurology | 1997 | 232 |
| 26 | Advances in the Treatment of Alzheimer’s Disease: Benefits of Dual Cholinesterase Inhibition | European Neurology | 2002 | 232 |
| 27 | Central Pontine Myelinolysis | European Neurology | 2002 | 220 |
| 28 | Diagnostic and Classification Criteria for the Guillain-Barré Syndrome | European Neurology | 2001 | 219 |
| 29 | Magnetic Resonance Signal Abnormalities in Asymptomatic Individuals: Their Incidence and Functional Correlates | European Neurology | 1989 | 213 |
| 30 | A Novel Depression Diagnosis Index Using Nonlinear Features in EEG Signals | European Neurology | 2015 | 201 |
| 31 | Motorische Funktion des Tektal- und Tegmentalgebietes; pp. 1–26 | European Neurology | 1946 | 189 |
| 32 | A Randomized, Double-Blind Comparison of Sumatriptan and Cafergot in the Acute Treatment of Migraine | European Neurology | 1991 | 189 |
| 33 | Botulinum Toxin: Mechanisms of Action | European Neurology | 2005 | 189 |
| 34 | Awareness of Cognitive Deficits and Anosognosia in Probable Alzheimer’s Disease | European Neurology | 1994 | 188 |
| 35 | Frontotemporal Dementia: Paroxetine as a Possible Treatment of Behavior Symptoms | European Neurology | 2003 | 186 |
| 36 | Dysphagia following Stroke | European Neurology | 2004 | 184 |
| 37 | Experience of Severe Fatigue Long after Stroke and Its Relation to Depressive Symptoms and Disease Characteristics | European Neurology | 2001 | 180 |
| 38 | Complications following Acute Ischemic Stroke | European Neurology | 2002 | 179 |
| 39 | Elevated Plasma Levels of Homocysteine inParkinson’s Disease | European Neurology | 1998 | 175 |
| 40 | Autonomic Side Effects of Botulinum Toxin Type B Treatment of Cervical Dystonia and Hyperhidrosis | European Neurology | 2003 | 175 |
| 41 | Sleep Problems in Multiple Sclerosis | European Neurology | 1994 | 174 |
| 42 | The Neurological Presentation of Ceruloplasmin Gene Mutations | European Neurology | 2008 | 171 |
| 43 | Restless Legs Syndrome among Working-Aged Women | European Neurology | 2001 | 170 |
| 44 | The Baffling Case of Ischemic Stroke Disappearance from the Casualty Department in the COVID-19 Era | European Neurology | 2020 | 168 |
| 45 | Qualitative Assessment of Cerebral Atrophy on MRI: Inter- and Intra-Observer Reproducibility in Dementia and Normal Aging | European Neurology | 1997 | 166 |
| 46 | Preclinical Studies on the Anti-Migraine Drug, Sumatriptan | European Neurology | 1991 | 164 |
| 47 | Cervical Artery Dissections | European Neurology | 1997 | 164 |
| 48 | Protein Analysis in Cerebrospinal Fluid | European Neurology | 1993 | 162 |
| 49 | Chronic Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson’s Disease: Effects on Cognition, Mood, Anxiety and Personality Traits | European Neurology | 2006 | 159 |
| 50 | Levodopa: Past, Present, and Future | European Neurology | 2009 | 158 |
